Westlake Corporation reported a net loss of $782 million for Q3 2025, primarily due to a $727 million non-cash goodwill impairment in its chlorovinyls operations. Net sales were $2.84 billion, down 9% year-over-year, while EBITDA excluding identified items was $313 million. The Housing and Infrastructure Products segment remained resilient with a 20% EBITDA margin, while the Performance and Essential Materials segment suffered from lower sales prices and volume, resulting in a 5% adjusted EBITDA margin.
Net sales were $2.84 billion, a 9% year-over-year decline.
A $727 million non-cash impairment charge resulted in a net loss of $782 million.
EBITDA excluding identified items was $313 million, with an 11% margin.
Housing and Infrastructure Products segment achieved a 20% EBITDA margin.
Westlake expects to improve profitability in 2026 through $200 million in cost savings and $100 million in annual loss reduction from facility closures, supported by better plant reliability and footprint optimization.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance